Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
Anagen effluvium with reversible scalp alopecia is a known side effect of chemotherapy. However, there are an increasing number of reports in the literature documenting permanent alopecia in patients treated with taxanes.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Athina Fonia, Carlo Cota, Jane F. Setterfield, Lynne J. Goldberg, David A. Fenton, Catherine M. Stefanato Tags: Dermatopathology Source Type: research
More News: Academies | Alopecia | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Dermatology | Hormonal Therapy | Hormones | Skin